Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Fyn: a novel molecular target in cancer.
Identification of a tissue-selective heat shock response regulatory network.
C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes.
Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients.
A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients. Expert Opin Drug Saf. 2015 Mar; 14(3):485-93.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Drug Interactions
Humans
Lung Neoplasms
Mutation
Protein Kinase Inhibitors
Pyrazoles
Pyridines
Quality of Life
Receptor Protein-Tyrosine Kinases
authors with profiles
Ravi Salgia